Mental Health Clinics in Garden City, ID Accepting Medicare
11 Mental Health Clinics found. Showing 1 - 11
 Kat Bowen Counseling Pllc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 123 E 44th St Ste A, Garden City, ID 83714 Phone: 208-484-3017 Fax: 208-658-4827 |
Pathways, Inc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 4094 W Chinden Blvd, #100, Garden City, ID 83714 Phone: 208-287-5350 Fax: 208-287-5351 |
Charly Read Counseling Pllc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 123 E 44th St, Garden City, ID 83714 Phone: 208-921-3197 Fax: 208-658-4827 |
Issaura Potter, Llc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 175 E 50th St, Garden City, ID 83714 Phone: 208-204-0451 |
Supportive Housing And Innovative Partnerships Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 305 E 37th St, Garden City, ID 83714 Phone: 208-331-0900 Fax: 208-331-0904 |
Ash Marie Counseling. Llc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 175 E 50th St, Garden City, ID 83714 Phone: 208-754-5142 |
Pioneer Health Resources Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5583 N Glenwood St, Garden City, ID 83714 Phone: 208-287-2564 Fax: 208-287-2570 |
David A Kent Md Chartered Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 5516 N Glenwood St, Ste B, Garden City, ID 83714 Phone: 208-863-0860 |
Caterpillar Counseling Clinic - Adolescent and Children Mental Health Medicare: Not Enrolled in Medicare Practice Location: 175 E 50th St, Garden City, ID 83714 Phone: 208-917-2024 |
Unicare Health Services Of Idaho L.l.c. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 125 E 50th St, Garden City, ID 83714 Phone: 208-747-5333 |
Nume Tms Clinics, Pllc Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 5561 N Glenwood St Ste B, Garden City, ID 83714 Phone: 208-954-5591 |
News Archive
TSRI researchers develop new approach to find how environmental estrogens impact public health
Breast cancer researchers from the Florida campus of The Scripps Research Institute have developed a novel approach for identifying how chemicals in the environment—called environmental estrogens—can produce infertility, abnormal reproductive development, including "precocious puberty," and promote breast cancer.
WVU RNI expands pioneering treatment for Alzheimer's to open the blood-brain barrier
A hospital nurse for 33 years, Nanette Miller would call her husband Frank at the end of each shift to let him know she was coming home. On Dec. 7, 2018, the phone call came with a somber declaration: "I can't do this anymore."
Voice cloning: an interview with Paul Welham, CEO, CereProc
CereVoice Me was essentially designed for those who had been diagnosed with MND/ALS and other illnesses that may cause an individual to lose the power of speech. CereProc identified that there was a gap in the market and pulled our resources together to build CereVoice Me, the goal of the service is to build a TTS voice efficiently and at a cost effective price.
Medisafe 1 presents barcoded syringe locking device at Medica 2010 Conference
Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company's exhibition of its barcoded syringe locking device generated overwhelming interest at the annual Medica 2010 Conference in Dusseldorf Germany, held November 16-19.
Antineoplaston treatment for gliomas granted orphan drug designation by FDA
The Burzynski Research Institute, Inc. (BRI) has announced that its antineoplaston A10 and antineoplaston AS2-1 therapy (ANP) has been granted orphan drug designation by the U.S. Food and Drug Administration ("FDA") for the treatment of gliomas. It is estimated that in 2008 more than 21,000 men and women in the U.S. will be diagnosed with this type of cancer, with prevalence estimated at approximately 84,000 cases.
› Verified 7 days ago